Allogene Therapeutics (ALLO) Q1 2025 Earnings
ALLO·Reported May 13, 2025·After market close
Diluted EPS came in at $-0.28 (+26.3% YoY).
Diluted EPS
$-0.28met estimate
Consensus: $-0.28
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Allogene Therapeutics's Q1 2025 earnings report.
Allogene Therapeutics (ALLO) reported Q1 2025 earnings on May 13, 2025 after market close.
Allogene Therapeutics reported diluted EPS of $-0.28 for Q1 2025.
EPS beat the consensus estimate of $-0.28 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 26.3% from $-0.38.
You can read the 10-Q periodic report (0001737287-25-000064) directly on SEC EDGAR. The filing index links above go to sec.gov.